Skip to content
The NDSS is administered by Diabetes Australia
Read aloud

NovoPen Echo recall


Novo Nordisk has identified that the insulin cartridge holder used in a small number of NovoPen Echo batches may crack or break if exposed to certain chemicals, for example certain cleaning agents.

This can result in the device delivering a smaller dose of insulin than expected, leading to high blood sugar levels. As a result, Novo Nordisk is recalling all pens in the affected batches.

Please note that there are no reported problems with the insulin being administered by these devices and that cracking and breaking should not occur if the device is cleaned in accordance with the instructions in the User Guide. The risk of patients experiencing problems as a result of this issue is considered extremely low.

More information from the Therapeutic Goods Administration about the recall, including affected batch numbers, is available here.